{"name":"Wanbangde Pharmaceutical Group Co., LTD","slug":"wanbangde-pharmaceutical-group-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Ginkgo leaf dropping pill","genericName":"Ginkgo leaf dropping pill","slug":"ginkgo-leaf-dropping-pill","indication":"Age-related cognitive decline and memory impairment","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Huperzine A Controlled-Release Tablets","genericName":"Huperzine A Controlled-Release Tablets","slug":"huperzine-a-controlled-release-tablets","indication":"Alzheimer's disease","status":"phase_2"}]}],"pipeline":[{"name":"Ginkgo leaf dropping pill","genericName":"Ginkgo leaf dropping pill","slug":"ginkgo-leaf-dropping-pill","phase":"marketed","mechanism":"Ginkgo leaf extract improves blood circulation and reduces blood viscosity to enhance cerebral blood flow and oxygen delivery.","indications":["Age-related cognitive decline and memory impairment","Cerebrovascular insufficiency","Tinnitus and vertigo"],"catalyst":""},{"name":"Huperzine A Controlled-Release Tablets","genericName":"Huperzine A Controlled-Release Tablets","slug":"huperzine-a-controlled-release-tablets","phase":"phase_2","mechanism":"Huperzine A is a reversible cholinesterase inhibitor that increases acetylcholine levels in the brain.","indications":["Alzheimer's disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQcVhpUTJDRjRCMXRCN1BxOVB6ZTh4OW1nUWJSVy1SRUd3NGd2S3dnVXRoVk5GTG1PY3VTcUliWlQybXhaLUl0V0xjcWw2TEtDdUxPZVNmU1ZJV2EtS1R0TEVjUGVaX1QzZmdaOXhvYTBJT25telhqRFhsVDZpZjdMQkFMVVBiRkZvdWJPOXlGWUotMzFsQU1EMVpqWlFnTlpkYWdNUk1UM0hhVzRHOEthSWQ0WXduTWF5WnZMZjROVGxYZmVxbUE?oc=5","date":"2026-03-30","type":"pipeline","source":"Markets Mojo","summary":"Wanbangde Pharmaceutical Hits Day High with 10.01% Surge in Stock Price - Markets Mojo","headline":"Wanbangde Pharmaceutical Hits Day High with 10.01% Surge in Stock Price","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQWlRHSUNTOVhENXpnZlFkTmZycjN5MVZDbWRPa0ZQU3dFM0dzNnpWUVdaQlpTR0FETTR3ZUh2c0Iwd3RFTGR3N3dITk1ncE90b0FZdHpZYjVhdy0tSE9pcFRKbkpSeWhOSXlmSXhDQXBkaUdaR0xkNmVwOGRERVF1dzREVHZWN2FDckpGY3UycDVLRW9YT3Y5eS1UdlFmZ3AyLVdrZ0R1LUVGVE1iUmNRLWRjMFpjR0RJam5RaExDaUZwakw3QlRWSzdjRQ?oc=5","date":"2026-03-27","type":"pipeline","source":"Markets Mojo","summary":"Wanbangde Pharmaceutical Hits Day High with 9.99% Surge Amid Market Decline - Markets Mojo","headline":"Wanbangde Pharmaceutical Hits Day High with 9.99% Surge Amid Market Decline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOcUV3NEdCZXA2eTdBSmRPNUx0cDVBdzdTQ0ZucGo4cEVXQk1oVmZRbTZ4OHFrcFd3UzIzN3ZiOGdGXy1hWDluNmxsSEx0VTZRQWZUbU9KSnRZZEF6VUZ6SkExTnkwN2owem9iRzFZQV9WUGtlVTBLRGx0T1VZdmVwV1czTkp0YnZ6bW9KaDcwQlB3aHpSWjJTYWdPNFFyWmx1SVRORHNTWGFGa01WSEJwd1BwYkVOZnNQLXRrdTBjX1YwY0FtOXc?oc=5","date":"2026-03-13","type":"pipeline","source":"Markets Mojo","summary":"Wanbangde Pharmaceutical Hits Day Low of CNY 18.10 Amid Price Pressure - Markets Mojo","headline":"Wanbangde Pharmaceutical Hits Day Low of CNY 18.10 Amid Price Pressure","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNVUVBQ2w1NkU4TTVwajEwTnNITTlXU2FBYWE1bm9fRjZ4UmhRRjhWUHY4dzRmQ3NnVGsyLXJyMzR1MTJSOGFLNXZPeGpJa2NPYkg2eDNzQ2NoUGE5WU1UdWI4QTBGRGtMTXJwUUQ0dUZUYnJlRkJVX1FOMWw3ZzVYTzV2QUJhMHc3ekl0UHZBSEQ0Z1ZTb0lwRVkyeTVNbUZfdElMZEhCb2RVckZxdUZoTThfNXZTV0JYLUNVYWYydGRVb0oz?oc=5","date":"2026-03-11","type":"pipeline","source":"Markets Mojo","summary":"Wanbangde Pharmaceutical Hits Day High with 4.88% Surge in Stock Price - Markets Mojo","headline":"Wanbangde Pharmaceutical Hits Day High with 4.88% Surge in Stock Price","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_2":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}